Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Stason WB, Weinstein MC: Allocation of resources to manage hypertension. N Engl J Med 1977, 296:732–739.
2. Andersson F, Kartman B, Andersson OK, et al.: Costeffectiveness of felodipine-metoprolol (Logimax) and enalapril in the treatment of hypertension. Clin Exp Hypertens 1998, 20:833–836.
3. Milne RJ, Vander Hoorn S, Jackson RT: A predictive model of the health benefits and cost-effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients. Pharmacoecon 1997, 2:384–408.
4. Pearce KA, Furberg CD, Psaty BM, Kirk J: Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens 1998, 11:618–629.
5. Johannesson M: The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment. J Hum Hypertens 1996, 10:S23-S26.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献